NCAPG2 and gastric adenocarcinoma: The PFI analysis suggested that NCAPG2 acts as a protective factor for 14 cancer types (ACC, BLCA, KIRP, KIPAN, KICH, GBMLGG, LUAD, LIHC, LGG, LUSC, PAAD, PRAD, MESO, and UVM) and as a risk factor for STAD (Fig. 4D).